Likewise, we recently reported that in NASH pathogenesis, toxic lipid-induced aberrant expression of LSEC VCAM1 mediates hepatic recruitment of pro-inflammatory monocytes, thereby promoting inflammation and fibrosis in the liver (5). The gene discussed is VCAM1; the disease is metabolic dysfunction-associated steatohepatitis.